| 23rd week of 2016 patent applcation highlights part 9 | ||
| Patent application number | Title | Published |
|---|---|---|
| 20160158215 | TRANSORAL DOSAGE FORMS COMPRISING SUFENTANIL AND NALOXONE | 2016-06-09 |
| 20160158216 | CRYSTALS OF LAQUINIMOD SODIUM AND IMPROVED PROCESS FOR THE MANUFACTURE THEREOF | 2016-06-09 |
| 20160158217 | Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGluR2-Negative Allosteric Modulators, Compositions, and Their Use | 2016-06-09 |
| 20160158218 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2016-06-09 |
| 20160158219 | USE OF AN H4 AGONIST MOLECULE TO TREAT ACUTE LEUKEMIA | 2016-06-09 |
| 20160158220 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | 2016-06-09 |
| 20160158221 | SUSTAINED RELEASE FORMULATION OF NALTREXONE | 2016-06-09 |
